Hook & thesis
PJT Partners has quietly become one of the better-positioned independent advisory firms in the market: disciplined capital allocation, near-zero financial leverage, and a business model that benefits from episodic but sizable deal fees. The shares are trading at $163.47 and, in our view, offer a favorable risk/reward today because the company converts a large portion of highly cyclical revenue into durable free cash flow.
We view PJT as a buy for traders looking to own a high-quality advisory franchise with strong cash generation, sensible balance-sheet metrics, and improving technical momentum. Our tactical trade plan is explicit: enter at $163.47, stop at $150.00, and target $185.00 over the next 180 trading days.
What PJT does and why the market should care
PJT Partners is an independent advisory-investment firm focused on strategic advisory, shareholder engagement, restructuring and special situations, and private fund advisory and placement. The company’s revenue is transaction-driven: advisory fees spike when large M&A, restructurings, or capital markets activity occurs. That cyclical profile is precisely why deal flow matters more than predictable recurring revenue lines for PJT.
Why this matters: when transaction volumes pick up, PJT’s margins and profitability expand quickly because it runs a relatively light balance sheet - it carries no financial leverage - and turns earnings into cash. That combination creates a structural advantage in periods of market activity: outsized EPS and even bigger free cash flow relative to peers that deploy more capital.
Key fundamentals and recent performance
Several concrete numbers underpin the bullish case:
- Market cap: about $4.22 billion.
- Current price: $163.47.
- Reported trailing earnings per share: $7.23, which implies an earnings multiple of roughly 22.6x at today’s price (163.47 / 7.23).
- Enterprise value: roughly $3.75 billion and EV/EBITDA near 9.7x.
- Price-to-sales: 2.25; price-to-book around 14.9 (reflecting a capital-light but highly profitable model).
- Free cash flow is substantial: $614.4 million (most recent reported figure), supporting dividend distributions and share repurchases.
- Balance sheet: effectively no debt (debt-to-equity 0) and a current ratio of 1.32, which reduces solvency concerns during slower deal cycles.
- Profitability: return on equity is very strong at 68.42%, a sign of high capital efficiency in the advisory model.
Operationally, PJT has shown the ability to grow top line during busy periods: the company reported GAAP revenue of $406.9 million in Q2 2025 (up 13% year-over-year) and beat on adjusted EPS. Strategic advisory led that upside while placement fees were softer, which is consistent with a business that reweights by product depending on where deal flow is strongest.
Valuation framing
At a market cap near $4.2 billion and enterprise value around $3.75 billion, PJT trades at a mid-teens to low-twenties multiple of earnings depending on which day you pick. Using the most recent trailing EPS of $7.23, today’s $163.47 price implies roughly a 22.6x P/E. EV/EBITDA of about 9.7x is reasonable for a profitable, low-capex advisory franchise with high free cash flow conversion.
This is not the cheapest stock in the financials universe, but the valuation becomes more palatable when you factor in:
- The company’s significant free cash flow ($614M) relative to its enterprise value - a point many growthy financial names cannot claim.
- The lack of financial leverage and a strong ROE, which supports durable capital returns to shareholders when deal activity normalizes or accelerates.
Put simply: you are paying for high-quality cash generation and a proven ability to monetize big advisory assignments, not a stretched capital structure.
Technical backdrop
Price momentum is constructive: the 10-day and 20-day simple moving averages sit near $160.27 and $157.03 respectively, and the 9-day EMA is tracking above the 21-day EMA, consistent with bullish momentum. RSI is neutral-to-favorable at 56, and the MACD histogram shows positive momentum. Short interest is meaningful (roughly 1.96M shares by the most recent settlement), which can amplify moves should deal flow news surprise to the upside.
Trade plan (actionable)
Direction: Long.
Entry price: 163.47
Stop loss: 150.00
Target: 185.00
Horizon: long term (180 trading days). We’re giving this trade roughly nine months because advisory revenues are lumpy: catalysts like announced M&A, restructurings, or higher capital markets activity can take time to translate into material booked fees and reported results. The horizon also allows for seasonal patterns in deal activity and gives time for any cyclical pickup to flow into earnings and cash flow.
Position sizing guidance: this is a medium-risk idea. Limit exposure to a size where a stop at $150 produces a manageable P&L outcome relative to risk tolerance. The stop protects against a sustained drop that would likely reflect either broader market stress or a tangible deterioration in deal prospects.
Catalysts to watch
- Improved M&A and restructuring deal flow across Q3/Q4 2026 - large mandates drive outsized quarterly revenue.
- Quarterly results that beat consensus on revenue and adjusted EPS, driven by strategic advisory fees (watch upcoming earnings release cadence).
- Announcements of large strategic advisory wins or exclusive roles in high-profile restructurings or buyouts.
- Share buybacks or sustained dividend increases funded by free cash flow that improve investor perception of capital returns.
Risks and counterarguments
- Deal-cycle sensitivity: PJT’s revenue is lumpy. A macro slowdown or weak capital markets backdrop can quickly reduce fee pools and cause earnings volatility.
- Concentration risk: A single large mandate can swing quarterly results materially. Disappointing outcomes on a big expected deal would pressure the stock.
- Valuation multiple compression: Given current multiples (roughly 22.6x trailing EPS), a re-rating lower - even if absolute fundamentals remain strong - can produce meaningful short-term losses.
- Insider behavior and analyst skepticism: There are periodic executive share sales (routine compensation or liquidity events) and a mixed analyst picture - price targets in prior months have ranged materially, signaling divergent views among professionals.
- Short-interest dynamics: Elevated short activity increases the risk of volatile intraday moves; conversely, positive surprises could trigger squeezes but negative data could accelerate downside as shorts pile on.
Counterargument: Critics will say you’re paying a premium for a company whose topline depends on an unpredictable M&A market. That logic has merit; if global deal activity cools further and remains tepid for multiple quarters, PJT’s earnings and cash conversion would be pressured, and the stock would likely de-rate. This is why the trade is sized as medium-risk and why we insist on a $150 stop to protect capital.
What would change our view
We would become less constructive if any of the following occur:
- Consecutive quarters of declining revenues and negative guidance, signaling a sustained drop in deal flow rather than normal cycle noise.
- A material change in capital allocation that increases leverage or reduces free cash flow conversion meaningfully.
- Loss of key partners or senior bankers who are core to winning large mandates, evidenced by departures or public client losses.
Conclusion
PJT Partners is a high-quality, capital-light advisory firm with strong free cash flow and attractive return metrics. The shares trade at a reasonable multiple given the company’s cash conversion and lack of financial leverage. For risk-aware traders willing to accept deal-cycle volatility, the combination of improving technicals, strong FCF, and the potential for outsized upside from a few large mandates supports a tactical buy at $163.47 with a $150 stop and $185 target over 180 trading days.
| Metric | Value |
|---|---|
| Current price | $163.47 |
| Market cap | $4,221,439,344 |
| Trailing EPS | $7.23 |
| Implied P/E (today) | ~22.6x |
| EV / EBITDA | ~9.7x |
| Free cash flow | $614,353,000 |
| Return on equity | 68.42% |
| Debt to equity | 0 |
Monitor: Deal flow headlines, quarterly revenue/fee disclosures, and any meaningful shifts in capital returns or leverage. A string of positive advisory wins or above-consensus results would validate the bullish thesis; sustained softness would force a reassessment.